Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Ipratropium Nasal Spray 0.03% Generic Name & Formulations
Legal Class
Rx
General Description
Ipratropium bromide 0.03% (21mcg/spray); aqueous soln.
Pharmacological Class
Anticholinergic.
How Supplied
Contact supplier
Manufacturer
Ipratropium Nasal Spray 0.03% Indications
Indications
Rhinorrhea associated with allergic and nonallergic perennial rhinitis.
Ipratropium Nasal Spray 0.03% Dosage and Administration
Adults and Children
<6yrs: not recommended. ≥6yrs: 2 sprays in each nostril 2–3 times daily.
Ipratropium Nasal Spray 0.03% Contraindications
Contraindications
Allergy to atropine or its derivatives.
Ipratropium Nasal Spray 0.03% Boxed Warnings
Not Applicable
Ipratropium Nasal Spray 0.03% Warnings/Precautions
Warnings/Precautions
Avoid eyes. Narrow-angle glaucoma. GI or GU obstruction. Pregnancy (Cat.B). Nursing mothers.
Ipratropium Nasal Spray 0.03% Pharmacokinetics
See Literature
Ipratropium Nasal Spray 0.03% Interactions
Not Applicable
Ipratropium Nasal Spray 0.03% Adverse Reactions
Adverse Reactions
Epistaxis, pharyngitis, nasal dryness or irritation, other nasal symptoms, nausea.
Ipratropium Nasal Spray 0.03% Clinical Trials
See Literature
Ipratropium Nasal Spray 0.03% Note
Notes
Formerly known under the brand name Atrovent.
Ipratropium Nasal Spray 0.03% Patient Counseling
See Literature
